カテゴリー： Market Monitor Global, 世界, 医療/バイオ

経皮投薬型スキンパッチの世界市場見通し2023年-2029年

◆英語タイトル：Transdermal Skin Patches Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8718 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月（※2025年版があります。お問い合わせください。） ◆ページ数：75 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Transdermal Skin Patches Market 調査レポートは次の情報を含め、グローバルにおけるの経皮投薬型スキンパッチ市場規模と予測を収録しています。・世界の経皮投薬型スキンパッチ市場：売上、2018年-2023年、2024年-2029年
・世界の経皮投薬型スキンパッチ市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の経皮投薬型スキンパッチ市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「接着剤中の薬剤」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

経皮投薬型スキンパッチのグローバル主要企業は、Johnson & Johnson、 Novartis AG、 Mylan N.V.、 Teva Pharmaceutical Industries、 Luye Pharma Group、 Hisamitsu Pharmaceutical、 Mundipharma International、 Purdue Pharmaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、経皮投薬型スキンパッチのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の経皮投薬型スキンパッチ市場：タイプ別、2018年-2023年、2024年-2029年
世界の経皮投薬型スキンパッチ市場：タイプ別市場シェア、2022年
・接着剤中の薬剤、マトリックス、リザーバー、蒸気、その他

世界の経皮投薬型スキンパッチ市場：用途別、2018年-2023年、2024年-2029年
世界の経皮投薬型スキンパッチ市場：用途別市場シェア、2022年
・病院薬局、小売薬局、オンライン薬局

世界の経皮投薬型スキンパッチ市場：地域・国別、2018年-2023年、2024年-2029年
世界の経皮投薬型スキンパッチ市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における経皮投薬型スキンパッチのグローバル売上、2018年-2023年
・主要企業における経皮投薬型スキンパッチのグローバル売上シェア、2022年
・主要企業における経皮投薬型スキンパッチのグローバル販売量、2018年-2023年
・主要企業における経皮投薬型スキンパッチのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Johnson & Johnson、 Novartis AG、 Mylan N.V.、 Teva Pharmaceutical Industries、 Luye Pharma Group、 Hisamitsu Pharmaceutical、 Mundipharma International、 Purdue Pharma

*************************************************************

・調査・分析レポートの概要
経皮投薬型スキンパッチ市場の定義
市場セグメント
世界の経皮投薬型スキンパッチ市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の経皮投薬型スキンパッチ市場規模
世界の経皮投薬型スキンパッチ市場規模：2022年 VS 2029年
世界の経皮投薬型スキンパッチ市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの経皮投薬型スキンパッチの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の経皮投薬型スキンパッチ製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：接着剤中の薬剤、マトリックス、リザーバー、蒸気、その他
経皮投薬型スキンパッチのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院薬局、小売薬局、オンライン薬局
経皮投薬型スキンパッチの用途別グローバル売上・予測

・地域別市場分析
地域別経皮投薬型スキンパッチ市場規模 2022年と2029年
地域別経皮投薬型スキンパッチ売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Johnson & Johnson、 Novartis AG、 Mylan N.V.、 Teva Pharmaceutical Industries、 Luye Pharma Group、 Hisamitsu Pharmaceutical、 Mundipharma International、 Purdue Pharma
...

This report aims to provide a comprehensive presentation of the global market for Transdermal Skin Patches, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal Skin Patches. This report contains market size and forecasts of Transdermal Skin Patches in global, including the following market information:
Global Transdermal Skin Patches Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Transdermal Skin Patches Market Sales, 2018-2023, 2024-2029, (M Pcs)
Global top five Transdermal Skin Patches companies in 2022 (%)
The global Transdermal Skin Patches market was valued at US$ 43 million in 2022 and is projected to reach US$ 51 million by 2029, at a CAGR of 2.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Drug in Adhesive Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Transdermal Skin Patches include Johnson & Johnson, Novartis AG, Mylan N.V., Teva Pharmaceutical Industries, Luye Pharma Group, Hisamitsu Pharmaceutical, Mundipharma International and Purdue Pharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Transdermal Skin Patches manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Transdermal Skin Patches Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (M Pcs)
Global Transdermal Skin Patches Market Segment Percentages, by Type, 2022 (%)
Drug in Adhesive
Matrix
Reservoir
Vapor
Others
Global Transdermal Skin Patches Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (M Pcs)
Global Transdermal Skin Patches Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Transdermal Skin Patches Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (M Pcs)
Global Transdermal Skin Patches Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Transdermal Skin Patches revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Transdermal Skin Patches revenues share in global market, 2022 (%)
Key companies Transdermal Skin Patches sales in global market, 2018-2023 (Estimated), (M Pcs)
Key companies Transdermal Skin Patches sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson & Johnson
Novartis AG
Mylan N.V.
Teva Pharmaceutical Industries
Luye Pharma Group
Hisamitsu Pharmaceutical
Mundipharma International
Purdue Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Transdermal Skin Patches, market overview.
Chapter 2: Global Transdermal Skin Patches market size in revenue and volume.
Chapter 3: Detailed analysis of Transdermal Skin Patches manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Transdermal Skin Patches in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Transdermal Skin Patches capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Transdermal Skin Patches Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Transdermal Skin Patches Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Transdermal Skin Patches Overall Market Size
2.1 Global Transdermal Skin Patches Market Size: 2022 VS 2029
2.2 Global Transdermal Skin Patches Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Transdermal Skin Patches Sales: 2018-2029
3 Company Landscape
3.1 Top Transdermal Skin Patches Players in Global Market
3.2 Top Global Transdermal Skin Patches Companies Ranked by Revenue
3.3 Global Transdermal Skin Patches Revenue by Companies
3.4 Global Transdermal Skin Patches Sales by Companies
3.5 Global Transdermal Skin Patches Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Transdermal Skin Patches Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Transdermal Skin Patches Product Type
3.8 Tier 1, Tier 2 and Tier 3 Transdermal Skin Patches Players in Global Market
3.8.1 List of Global Tier 1 Transdermal Skin Patches Companies
3.8.2 List of Global Tier 2 and Tier 3 Transdermal Skin Patches Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Transdermal Skin Patches Market Size Markets, 2022 & 2029
4.1.2 Drug in Adhesive
4.1.3 Matrix
4.1.4 Reservoir
4.1.5 Vapor
4.1.6 Others
4.2 By Type – Global Transdermal Skin Patches Revenue & Forecasts
4.2.1 By Type – Global Transdermal Skin Patches Revenue, 2018-2023
4.2.2 By Type – Global Transdermal Skin Patches Revenue, 2024-2029
4.2.3 By Type – Global Transdermal Skin Patches Revenue Market Share, 2018-2029
4.3 By Type – Global Transdermal Skin Patches Sales & Forecasts
4.3.1 By Type – Global Transdermal Skin Patches Sales, 2018-2023
4.3.2 By Type – Global Transdermal Skin Patches Sales, 2024-2029
4.3.3 By Type – Global Transdermal Skin Patches Sales Market Share, 2018-2029
4.4 By Type – Global Transdermal Skin Patches Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Transdermal Skin Patches Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application – Global Transdermal Skin Patches Revenue & Forecasts
5.2.1 By Application – Global Transdermal Skin Patches Revenue, 2018-2023
5.2.2 By Application – Global Transdermal Skin Patches Revenue, 2024-2029
5.2.3 By Application – Global Transdermal Skin Patches Revenue Market Share, 2018-2029
5.3 By Application – Global Transdermal Skin Patches Sales & Forecasts
5.3.1 By Application – Global Transdermal Skin Patches Sales, 2018-2023
5.3.2 By Application – Global Transdermal Skin Patches Sales, 2024-2029
5.3.3 By Application – Global Transdermal Skin Patches Sales Market Share, 2018-2029
5.4 By Application – Global Transdermal Skin Patches Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Transdermal Skin Patches Market Size, 2022 & 2029
6.2 By Region – Global Transdermal Skin Patches Revenue & Forecasts
6.2.1 By Region – Global Transdermal Skin Patches Revenue, 2018-2023
6.2.2 By Region – Global Transdermal Skin Patches Revenue, 2024-2029
6.2.3 By Region – Global Transdermal Skin Patches Revenue Market Share, 2018-2029
6.3 By Region – Global Transdermal Skin Patches Sales & Forecasts
6.3.1 By Region – Global Transdermal Skin Patches Sales, 2018-2023
6.3.2 By Region – Global Transdermal Skin Patches Sales, 2024-2029
6.3.3 By Region – Global Transdermal Skin Patches Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Transdermal Skin Patches Revenue, 2018-2029
6.4.2 By Country – North America Transdermal Skin Patches Sales, 2018-2029
6.4.3 US Transdermal Skin Patches Market Size, 2018-2029
6.4.4 Canada Transdermal Skin Patches Market Size, 2018-2029
6.4.5 Mexico Transdermal Skin Patches Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Transdermal Skin Patches Revenue, 2018-2029
6.5.2 By Country – Europe Transdermal Skin Patches Sales, 2018-2029
6.5.3 Germany Transdermal Skin Patches Market Size, 2018-2029
6.5.4 France Transdermal Skin Patches Market Size, 2018-2029
6.5.5 U.K. Transdermal Skin Patches Market Size, 2018-2029
6.5.6 Italy Transdermal Skin Patches Market Size, 2018-2029
6.5.7 Russia Transdermal Skin Patches Market Size, 2018-2029
6.5.8 Nordic Countries Transdermal Skin Patches Market Size, 2018-2029
6.5.9 Benelux Transdermal Skin Patches Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Transdermal Skin Patches Revenue, 2018-2029
6.6.2 By Region – Asia Transdermal Skin Patches Sales, 2018-2029
6.6.3 China Transdermal Skin Patches Market Size, 2018-2029
6.6.4 Japan Transdermal Skin Patches Market Size, 2018-2029
6.6.5 South Korea Transdermal Skin Patches Market Size, 2018-2029
6.6.6 Southeast Asia Transdermal Skin Patches Market Size, 2018-2029
6.6.7 India Transdermal Skin Patches Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Transdermal Skin Patches Revenue, 2018-2029
6.7.2 By Country – South America Transdermal Skin Patches Sales, 2018-2029
6.7.3 Brazil Transdermal Skin Patches Market Size, 2018-2029
6.7.4 Argentina Transdermal Skin Patches Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Transdermal Skin Patches Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Transdermal Skin Patches Sales, 2018-2029
6.8.3 Turkey Transdermal Skin Patches Market Size, 2018-2029
6.8.4 Israel Transdermal Skin Patches Market Size, 2018-2029
6.8.5 Saudi Arabia Transdermal Skin Patches Market Size, 2018-2029
6.8.6 UAE Transdermal Skin Patches Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Transdermal Skin Patches Major Product Offerings
7.1.4 Johnson & Johnson Transdermal Skin Patches Sales and Revenue in Global (2018-2023)
7.1.5 Johnson & Johnson Key News & Latest Developments
7.2 Novartis AG
7.2.1 Novartis AG Company Summary
7.2.2 Novartis AG Business Overview
7.2.3 Novartis AG Transdermal Skin Patches Major Product Offerings
7.2.4 Novartis AG Transdermal Skin Patches Sales and Revenue in Global (2018-2023)
7.2.5 Novartis AG Key News & Latest Developments
7.3 Mylan N.V.
7.3.1 Mylan N.V. Company Summary
7.3.2 Mylan N.V. Business Overview
7.3.3 Mylan N.V. Transdermal Skin Patches Major Product Offerings
7.3.4 Mylan N.V. Transdermal Skin Patches Sales and Revenue in Global (2018-2023)
7.3.5 Mylan N.V. Key News & Latest Developments
7.4 Teva Pharmaceutical Industries
7.4.1 Teva Pharmaceutical Industries Company Summary
7.4.2 Teva Pharmaceutical Industries Business Overview
7.4.3 Teva Pharmaceutical Industries Transdermal Skin Patches Major Product Offerings
7.4.4 Teva Pharmaceutical Industries Transdermal Skin Patches Sales and Revenue in Global (2018-2023)
7.4.5 Teva Pharmaceutical Industries Key News & Latest Developments
7.5 Luye Pharma Group
7.5.1 Luye Pharma Group Company Summary
7.5.2 Luye Pharma Group Business Overview
7.5.3 Luye Pharma Group Transdermal Skin Patches Major Product Offerings
7.5.4 Luye Pharma Group Transdermal Skin Patches Sales and Revenue in Global (2018-2023)
7.5.5 Luye Pharma Group Key News & Latest Developments
7.6 Hisamitsu Pharmaceutical
7.6.1 Hisamitsu Pharmaceutical Company Summary
7.6.2 Hisamitsu Pharmaceutical Business Overview
7.6.3 Hisamitsu Pharmaceutical Transdermal Skin Patches Major Product Offerings
7.6.4 Hisamitsu Pharmaceutical Transdermal Skin Patches Sales and Revenue in Global (2018-2023)
7.6.5 Hisamitsu Pharmaceutical Key News & Latest Developments
7.7 Mundipharma International
7.7.1 Mundipharma International Company Summary
7.7.2 Mundipharma International Business Overview
7.7.3 Mundipharma International Transdermal Skin Patches Major Product Offerings
7.7.4 Mundipharma International Transdermal Skin Patches Sales and Revenue in Global (2018-2023)
7.7.5 Mundipharma International Key News & Latest Developments
7.8 Purdue Pharma
7.8.1 Purdue Pharma Company Summary
7.8.2 Purdue Pharma Business Overview
7.8.3 Purdue Pharma Transdermal Skin Patches Major Product Offerings
7.8.4 Purdue Pharma Transdermal Skin Patches Sales and Revenue in Global (2018-2023)
7.8.5 Purdue Pharma Key News & Latest Developments
8 Global Transdermal Skin Patches Production Capacity, Analysis
8.1 Global Transdermal Skin Patches Production Capacity, 2018-2029
8.2 Transdermal Skin Patches Production Capacity of Key Manufacturers in Global Market
8.3 Global Transdermal Skin Patches Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Transdermal Skin Patches Supply Chain Analysis
10.1 Transdermal Skin Patches Industry Value Chain
10.2 Transdermal Skin Patches Upstream Market
10.3 Transdermal Skin Patches Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Transdermal Skin Patches Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Transdermal Skin Patches in Global Market
Table 2. Top Transdermal Skin Patches Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Transdermal Skin Patches Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Transdermal Skin Patches Revenue Share by Companies, 2018-2023
Table 5. Global Transdermal Skin Patches Sales by Companies, (M Pcs), 2018-2023
Table 6. Global Transdermal Skin Patches Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Transdermal Skin Patches Price (2018-2023) & (USD/Pcs)
Table 8. Global Manufacturers Transdermal Skin Patches Product Type
Table 9. List of Global Tier 1 Transdermal Skin Patches Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Transdermal Skin Patches Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Transdermal Skin Patches Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Transdermal Skin Patches Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Transdermal Skin Patches Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Transdermal Skin Patches Sales (M Pcs), 2018-2023
Table 15. By Type - Global Transdermal Skin Patches Sales (M Pcs), 2024-2029
Table 16. By Application – Global Transdermal Skin Patches Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Transdermal Skin Patches Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Transdermal Skin Patches Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Transdermal Skin Patches Sales (M Pcs), 2018-2023
Table 20. By Application - Global Transdermal Skin Patches Sales (M Pcs), 2024-2029
Table 21. By Region – Global Transdermal Skin Patches Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Transdermal Skin Patches Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Transdermal Skin Patches Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Transdermal Skin Patches Sales (M Pcs), 2018-2023
Table 25. By Region - Global Transdermal Skin Patches Sales (M Pcs), 2024-2029
Table 26. By Country - North America Transdermal Skin Patches Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Transdermal Skin Patches Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Transdermal Skin Patches Sales, (M Pcs), 2018-2023
Table 29. By Country - North America Transdermal Skin Patches Sales, (M Pcs), 2024-2029
Table 30. By Country - Europe Transdermal Skin Patches Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Transdermal Skin Patches Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Transdermal Skin Patches Sales, (M Pcs), 2018-2023
Table 33. By Country - Europe Transdermal Skin Patches Sales, (M Pcs), 2024-2029
Table 34. By Region - Asia Transdermal Skin Patches Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Transdermal Skin Patches Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Transdermal Skin Patches Sales, (M Pcs), 2018-2023
Table 37. By Region - Asia Transdermal Skin Patches Sales, (M Pcs), 2024-2029
Table 38. By Country - South America Transdermal Skin Patches Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Transdermal Skin Patches Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Transdermal Skin Patches Sales, (M Pcs), 2018-2023
Table 41. By Country - South America Transdermal Skin Patches Sales, (M Pcs), 2024-2029
Table 42. By Country - Middle East & Africa Transdermal Skin Patches Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Transdermal Skin Patches Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Transdermal Skin Patches Sales, (M Pcs), 2018-2023
Table 45. By Country - Middle East & Africa Transdermal Skin Patches Sales, (M Pcs), 2024-2029
Table 46. Johnson & Johnson Company Summary
Table 47. Johnson & Johnson Transdermal Skin Patches Product Offerings
Table 48. Johnson & Johnson Transdermal Skin Patches Sales (M Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 49. Johnson & Johnson Key News & Latest Developments
Table 50. Novartis AG Company Summary
Table 51. Novartis AG Transdermal Skin Patches Product Offerings
Table 52. Novartis AG Transdermal Skin Patches Sales (M Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 53. Novartis AG Key News & Latest Developments
Table 54. Mylan N.V. Company Summary
Table 55. Mylan N.V. Transdermal Skin Patches Product Offerings
Table 56. Mylan N.V. Transdermal Skin Patches Sales (M Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 57. Mylan N.V. Key News & Latest Developments
Table 58. Teva Pharmaceutical Industries Company Summary
Table 59. Teva Pharmaceutical Industries Transdermal Skin Patches Product Offerings
Table 60. Teva Pharmaceutical Industries Transdermal Skin Patches Sales (M Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 61. Teva Pharmaceutical Industries Key News & Latest Developments
Table 62. Luye Pharma Group Company Summary
Table 63. Luye Pharma Group Transdermal Skin Patches Product Offerings
Table 64. Luye Pharma Group Transdermal Skin Patches Sales (M Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 65. Luye Pharma Group Key News & Latest Developments
Table 66. Hisamitsu Pharmaceutical Company Summary
Table 67. Hisamitsu Pharmaceutical Transdermal Skin Patches Product Offerings
Table 68. Hisamitsu Pharmaceutical Transdermal Skin Patches Sales (M Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 69. Hisamitsu Pharmaceutical Key News & Latest Developments
Table 70. Mundipharma International Company Summary
Table 71. Mundipharma International Transdermal Skin Patches Product Offerings
Table 72. Mundipharma International Transdermal Skin Patches Sales (M Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 73. Mundipharma International Key News & Latest Developments
Table 74. Purdue Pharma Company Summary
Table 75. Purdue Pharma Transdermal Skin Patches Product Offerings
Table 76. Purdue Pharma Transdermal Skin Patches Sales (M Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 77. Purdue Pharma Key News & Latest Developments
Table 78. Transdermal Skin Patches Production Capacity (M Pcs) of Key Manufacturers in Global Market, 2021-2023 (M Pcs)
Table 79. Global Transdermal Skin Patches Capacity Market Share of Key Manufacturers, 2021-2023
Table 80. Global Transdermal Skin Patches Production by Region, 2018-2023 (M Pcs)
Table 81. Global Transdermal Skin Patches Production by Region, 2024-2029 (M Pcs)
Table 82. Transdermal Skin Patches Market Opportunities & Trends in Global Market
Table 83. Transdermal Skin Patches Market Drivers in Global Market
Table 84. Transdermal Skin Patches Market Restraints in Global Market
Table 85. Transdermal Skin Patches Raw Materials
Table 86. Transdermal Skin Patches Raw Materials Suppliers in Global Market
Table 87. Typical Transdermal Skin Patches Downstream
Table 88. Transdermal Skin Patches Downstream Clients in Global Market
Table 89. Transdermal Skin Patches Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Transdermal Skin Patches Segment by Type in 2022
Figure 2. Transdermal Skin Patches Segment by Application in 2022
Figure 3. Global Transdermal Skin Patches Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Transdermal Skin Patches Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Transdermal Skin Patches Revenue, 2018-2029 (US$, Mn)
Figure 7. Transdermal Skin Patches Sales in Global Market: 2018-2029 (M Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Transdermal Skin Patches Revenue in 2022
Figure 9. By Type - Global Transdermal Skin Patches Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Transdermal Skin Patches Revenue Market Share, 2018-2029
Figure 11. By Type - Global Transdermal Skin Patches Sales Market Share, 2018-2029
Figure 12. By Type - Global Transdermal Skin Patches Price (USD/Pcs), 2018-2029
Figure 13. By Application - Global Transdermal Skin Patches Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Transdermal Skin Patches Revenue Market Share, 2018-2029
Figure 15. By Application - Global Transdermal Skin Patches Sales Market Share, 2018-2029
Figure 16. By Application - Global Transdermal Skin Patches Price (USD/Pcs), 2018-2029
Figure 17. By Region - Global Transdermal Skin Patches Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Transdermal Skin Patches Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Transdermal Skin Patches Revenue Market Share, 2018-2029
Figure 20. By Region - Global Transdermal Skin Patches Sales Market Share, 2018-2029
Figure 21. By Country - North America Transdermal Skin Patches Revenue Market Share, 2018-2029
Figure 22. By Country - North America Transdermal Skin Patches Sales Market Share, 2018-2029
Figure 23. US Transdermal Skin Patches Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Transdermal Skin Patches Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Transdermal Skin Patches Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Transdermal Skin Patches Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Transdermal Skin Patches Sales Market Share, 2018-2029
Figure 28. Germany Transdermal Skin Patches Revenue, (US$, Mn), 2018-2029
Figure 29. France Transdermal Skin Patches Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Transdermal Skin Patches Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Transdermal Skin Patches Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Transdermal Skin Patches Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Transdermal Skin Patches Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Transdermal Skin Patches Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Transdermal Skin Patches Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Transdermal Skin Patches Sales Market Share, 2018-2029
Figure 37. China Transdermal Skin Patches Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Transdermal Skin Patches Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Transdermal Skin Patches Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Transdermal Skin Patches Revenue, (US$, Mn), 2018-2029
Figure 41. India Transdermal Skin Patches Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Transdermal Skin Patches Revenue Market Share, 2018-2029
Figure 43. By Country - South America Transdermal Skin Patches Sales Market Share, 2018-2029
Figure 44. Brazil Transdermal Skin Patches Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Transdermal Skin Patches Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Transdermal Skin Patches Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Transdermal Skin Patches Sales Market Share, 2018-2029
Figure 48. Turkey Transdermal Skin Patches Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Transdermal Skin Patches Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Transdermal Skin Patches Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Transdermal Skin Patches Revenue, (US$, Mn), 2018-2029
Figure 52. Global Transdermal Skin Patches Production Capacity (M Pcs), 2018-2029
Figure 53. The Percentage of Production Transdermal Skin Patches by Region, 2022 VS 2029
Figure 54. Transdermal Skin Patches Industry Value Chain
Figure 55. Marketing Channels

※参考情報

経皮投薬型スキンパッチは、医薬品を皮膚を通じて体内に投与するためのデバイスです。この技術は、医薬品を直接血流に送り込むことで、効果的な治療を実現するための手段として広く利用されています。従来の経口薬や注射に比べて、経皮投薬は多くの利点があります。

経皮投薬型スキンパッチの最大の特徴は、その使いやすさと患者のコンプライアンス向上です。スキンパッチは、皮膚に貼り付けるだけで簡単に使用でき、定期的に投与する必要がある薬剤でも、一定の間隔で持続的に効果を発揮します。これにより、薬の取りこぼしや過剰投与のリスクを軽減し、患者の治療に対する理解と協力が得やすくなります。

この経皮投薬型スキンパッチは、主に以下のような種類に分類されます。まず、薬剤を浸透させるための膜を持つ「浸透パッチ」があります。これには、薬剤を皮膚の深部まで届ける能力があり、疼痛管理やホルモン治療など、さまざまな用途で利用されています。次に「マイクロニードルパッチ」は、微細な針を使用して薬剤を皮膚に導入します。この技術によって、痛みを最小限に抑えつつ、迅速な薬物吸収が可能となります。

経皮投薬型スキンパッチの用途は多岐にわたります。例えば、疼痛緩和や慢性疾患の管理に使用されることが多く、ニコチンパッチやホルモン療法用パッチなどがあります。また、最近ではワクチンや抗ウイルス薬の経皮投与試みも進められており、新たな治療法の可能性が探求されています。特に、慢性的な病気の管理においては、患者が自己管理しやすい方法として注目されています。

関連技術としては、ナノテクノロジーやドラッグデリバリーシステムがあります。これらの技術を用いることで、薬剤の浸透効率を高めることができ、また副作用のリスクを軽減することも可能です。特に、ナノ粒子を活用することで、より小さな粒子として薬剤を投与することが可能になり、肌のバリアを越えて体内に効果的に届けることができるようになります。

経皮投薬型スキンパッチの課題としては、皮膚の特性や薬剤の性質によって吸収率が異なるため、個体間での反応のばらつきがあります。また、皮膚の状態や温度なども影響を及ぼすため、個別の治療戦略が求められます。さらに、スキンパッチの使用によるアレルギー反応や皮膚の刺激なども十分に考慮する必要があります。

未来においては、これらの技術の進化に伴い、より多くの疾患に対する経皮投薬型スキンパッチの利用が期待されています。スマートパッチと呼ばれる、センサーを搭載したデバイスが開発され、リアルタイムで患者の状態をモニタリングし、必要に応じて薬剤の投与を調整することが可能になるなど、個別化医療の実現へとつながるでしょう。

経皮投薬型スキンパッチは、医療技術の進歩とともに、その可能性を広げています。これにより、より多くの患者にとって安全で効果的な治療法となることが期待されます。医療現場における利便性や患者への配慮を考慮した新しい治療法として、これからの発展に注目が集まっています。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 経皮投薬型スキンパッチの世界市場見通し2023年-2029年(Transdermal Skin Patches Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

経皮投薬型スキンパッチの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp